SCHEMBL7672897

SCHEMBL7672897

CCCCn1cnc2c(OC)nc(Nc3ccc4c(c3)OCO4)nc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.50
▸ PDGFRA P16234 8/20 0.43
▸ CCNE1 P24864 8/20 0.43
▸ CDK2 P24941 8/20 0.43
▸ ALDH1A1 P00352 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ PDE5A O76074 1/20 0.40
▸ TUBB4A P04350 1/20 0.39
▸ TUBB P07437 1/20 0.39
▸ TUBA3C P0DPH7 1/20 0.39
▸ TUBA1B P68363 1/20 0.39
▸ TUBA4A P68366 1/20 0.39
▸ TUBB4B P68371 1/20 0.39
▸ TUBB3 Q13509 1/20 0.39
▸ TUBB2A Q13885 1/20 0.39
▸ TUBB8 Q3ZCM7 1/20 0.39
▸ TUBA3E Q6PEY2 1/20 0.39
▸ TUBA1A Q71U36 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666144 0.83 CDK4 (0.45) LMNAPDGFRACCNE1CDK2ALDH1A1
SCHEMBL7674300 0.82 CTSL (0.50) PDGFRACCNE1CDK2
SCHEMBL7358873 0.81 CTSL (0.46) PDGFRACCNE1CDK2
SCHEMBL7672132 0.81 GALR2 (0.44) LMNAPDGFRACCNE1CDK2MAPT
SCHEMBL7661515 0.81 CCNE1 (0.54) PDGFRACCNE1CDK2
SCHEMBL7673595 0.80 KDM4E (0.45) PDGFRACCNE1CDK2RAB9AMAPT
SCHEMBL7674302 0.79 PDGFRA (0.44) PDGFRACCNE1CDK2MEN1KMT2A
SCHEMBL7674135 0.78 PDGFRA (0.43) PDGFRACCNE1CDK2
SCHEMBL7672863 0.77 PDGFRA (0.52) PDGFRACCNE1CDK2
SCHEMBL7671191 0.75 GBA1 (0.48) PDGFRACCNE1CDK2ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 — — US claimed
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 — — US disclosed
Send feedback